A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to prevent unwanted interactions between medications and other environmental, genetic, and lifestyle factors, in order to optimize therapeutic efficacy.
CDC: Infant Syphilis Spike Continues
Syphilis case rates among U.S. newborns soared from 334 in 2012 to more than 3,700 last year, according to the CDC, which recommended “concerted action”
November 8, 2023